Levels of matrix metalloproteinase-2 and metalloproteinase-9 in the cerebrospinal fluid of dogs with visceral leishmaniasis

被引:20
|
作者
Marangoni, N. R. [1 ]
Melo, G. D. [1 ]
Moraes, O. C. [1 ]
Souza, M. S. [1 ]
Perri, S. H. V. [2 ]
Machado, G. F. [1 ]
机构
[1] UNESP Univ Estadual Paulista, Dept Anim Clin Surg & Reprod, Coll Vet Med, Sao Paulo, Brazil
[2] UNESP Univ Estadual Paulista, Dept Anim Prod & Hlth, Coll Vet Med, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
central nervous system; inflammation; Leishmania chagasi; MMP-2; MMP-9; zymography; ENTRY; SERUM;
D O I
10.1111/j.1365-3024.2011.01285.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Inflammation causes increases in the level of matrix metalloproteinases (MMPs), which, in central nervous system (CNS), are associated with neuroinflammation and disruption of blood-brain barrier. Analysis of cerebrospinal fluid (CSF) is pivotal for detecting diseases in CNS and, although a specific diagnosis may not be achieved, this analysis is helpful to confirm the diagnosis or to rule out relevant differential diagnoses. This study examined the levels of MMP-2 and MMP-9 in the CSF of dogs using gelatin zymography to verify possible alterations in these enzymes during natural systemic infection with Leishmania chagasi. Latent and active forms of MMP-2 were detected in some dogs of both groups, with high levels in the control group. In contrast, latent and active forms of MMP-9 were detected only in some animals with leishmaniasis. These results clearly demonstrate that MMP-9 is elevated in CSF of dogs with visceral leishmaniasis (VL). Although these results are preliminary, they suggest that MMP-9 might play a role in disruption of blood-brain barrier and/or blood-CSF barrier. While the presence of MMPs in CSF is not a condition exclusive to VL, their presence and persistence in CSF supports the hypothesis of an inflammatory state within CNS of dogs with VL.
引用
收藏
页码:330 / 334
页数:5
相关论文
共 50 条
  • [31] DEGRADATION OF VITRONECTIN BY MATRIX METALLOPROTEINASE-1, METALLOPROTEINASE-2, METALLOPROTEINASE-3, METALLOPROTEINASE-7 AND METALLOPROTEINASE-9
    IMAI, K
    SHIKATA, H
    OKADA, Y
    FEBS LETTERS, 1995, 369 (2-3): : 249 - 251
  • [32] Immunohistochemical studies of the expression of matrix metalloproteinase-2 and metalloproteinase-9 in human prostate cancer
    Zeng, Hanqing
    Xiao, Yajun
    Lu, Gongchen
    Chen, Yong
    Journal of Huazhong University of Science and Technology - Medical Science, 2003, 23 (04): : 373 - 374
  • [33] Immunohistochemical studies of the expression of matrix metalloproteinase-2 and metalloproteinase-9 in human prostate cancer
    Zeng Hanqing
    Xiao Yajun
    Lu Gongchen
    Chen Yong
    Current Medical Science, 2003, 23 (4) : 373 - 374
  • [34] Immunohistochemical Studies of the Expression of Matrix Metalloproteinase-2 and Metalloproteinase-9 in Human Prostate Cancer
    曾汉青
    肖亚军
    鲁功成
    陈勇
    华中科技大学学报(医学英德文版), 2003, (04) : 373 - 374
  • [35] GALECTIN-3 IS A NOVEL SUBSTRATE FOR HUMAN MATRIX METALLOPROTEINASE-2 AND METALLOPROTEINASE-9
    OCHIENG, J
    FRIDMAN, R
    NANGIAMAKKER, P
    KLEINER, DE
    LIOTTA, LA
    STETLERSTEVENSON, WG
    RAZ, A
    BIOCHEMISTRY, 1994, 33 (47) : 14109 - 14114
  • [36] Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid
    Niimi, Y
    Pawankar, R
    Kawana, S
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2006, 139 (02) : 104 - 113
  • [37] Matrix metalloproteinase-2 and matrix metalloproteinase-9 serum levels in patients with vertebrobasilar dolichoectasia with and without stroke: case–control study
    Juan Manuel Marquez-Romero
    Raúl Díaz-Molina
    Bernardo César Hernández-Curiel
    Dulce María Bonifacio-Delgadillo
    Carlos Alberto Prado-Aguilar
    Neuroradiology, 2022, 64 : 1187 - 1193
  • [38] Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
    Beranek, Michal
    Kolar, Petr
    Tschoplova, Svatava
    Kankova, Katerina
    Vasku, Anna
    MOLECULAR VISION, 2008, 14 (131-32): : 1114 - 1121
  • [39] Contribution of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 to Upper Tract Urothelial Cancer Risk in Taiwan
    Wang, Bo-Ren
    Ma, Hung-Huan
    Chang, Chao-Hsiang
    Liao, Cheng-Hsi
    Chang, Wen-Shin
    Mong, Mei-Chin
    Yang, Ya-Chen
    Gu, Jian
    Bau, Da-Tian
    Tsai, Chia-Wen
    LIFE-BASEL, 2024, 14 (07):
  • [40] Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
    Wei, Ting
    Zhang, Haihong
    Cetin, Neslihan
    Miller, Emily
    Moak, Teri
    Suen, James Y.
    Richter, Gresham T.
    SCIENTIFIC REPORTS, 2016, 6